According to new research, compounds in cannabis can prevent COVID-19 virus from infecting healthy human cells. The Journal of Natural Products issued a report titled “Cannabinoids Block Cellular Entry of SARS-CoV-2 and Emerging Variants” on January 10, 2022.
Researchers showed that two cannabinoid acids present in hemp genotypes of cannabis – cannabigerolic acid (CBGA) and cannabidiolic acid (GBDA) – can connect to the virus’s spike protein, that infect cells with COVID-19.
When attached to the spike protein, these chemicals have the ability to block the virus from entering cells and causing infection, opening up new paths for disease prevention and treatment.
The findings suggests that cannabis might be utilized in the creation of future medications to prevent or cure COVID-19, though further research is needed.
The scientists who conducted the study have said that while smoking weed won’t necessarily stop infection, their research opens up new possibilities for cannabis properties to be used in medicine.
“We know that CBD, CBG and THC are not active against the virus. So, we would recommend in favor of an oral administration of these compounds instead of smoking them, inhaling them from vaping.
“We certainly expect [smoking cannabis] would have a reduced effect. I haven’t done the experiments to see how rapidly this conversion takes place and what the temperature limits are. But we do know that the cannabidiolic acid is unstable in heat”.